AstraZeneca PLC (AZNCF)
130.24
+1.04
(+0.80%)
USD |
OTCM |
Nov 14, 16:00
AstraZeneca Price to Book Value: 5.110 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 5.069 |
| November 12, 2024 | 5.038 |
| November 11, 2024 | 4.975 |
| November 08, 2024 | 5.012 |
| November 07, 2024 | 4.965 |
| November 06, 2024 | 4.965 |
| November 05, 2024 | 5.141 |
| November 04, 2024 | 5.588 |
| November 01, 2024 | 5.605 |
| October 31, 2024 | 5.568 |
| October 30, 2024 | 5.866 |
| October 29, 2024 | 5.872 |
| October 28, 2024 | 5.830 |
| October 25, 2024 | 5.830 |
| October 24, 2024 | 5.952 |
| October 23, 2024 | 5.977 |
| October 22, 2024 | 6.136 |
| October 21, 2024 | 6.067 |
| October 18, 2024 | 6.194 |
| October 17, 2024 | 6.063 |
| October 16, 2024 | 6.030 |
| October 15, 2024 | 6.030 |
| October 14, 2024 | 5.782 |
| October 11, 2024 | 5.782 |
| October 10, 2024 | 5.782 |
| Date | Value |
|---|---|
| October 09, 2024 | 5.832 |
| October 08, 2024 | 5.832 |
| October 07, 2024 | 6.110 |
| October 04, 2024 | 5.990 |
| October 03, 2024 | 5.995 |
| October 02, 2024 | 6.236 |
| October 01, 2024 | 6.102 |
| September 30, 2024 | 6.060 |
| September 27, 2024 | 6.060 |
| September 26, 2024 | 6.015 |
| September 25, 2024 | 6.015 |
| September 24, 2024 | 5.859 |
| September 23, 2024 | 6.087 |
| September 20, 2024 | 6.087 |
| September 19, 2024 | 6.189 |
| September 18, 2024 | 6.433 |
| September 17, 2024 | 6.191 |
| September 16, 2024 | 6.16 |
| September 13, 2024 | 6.205 |
| September 12, 2024 | 6.136 |
| September 11, 2024 | 6.287 |
| September 10, 2024 | 6.287 |
| September 09, 2024 | 6.281 |
| September 06, 2024 | 6.630 |
| September 05, 2024 | 6.464 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.182
Minimum
Dec 13 2021
13.56
Maximum
May 21 2020
7.471
Average
6.086
Median
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 1.567 |
| Biodexa Pharmaceuticals PLC | 0.2536 |
| Verona Pharma PLC | 22.17 |
| NuCana PLC | 0.7268 |
| Autolus Therapeutics PLC | 1.520 |
Price to Book Value Related Metrics
| PE Ratio | 31.46 |
| PS Ratio | 4.140 |
| PEG Ratio | 6.921 |
| Price to Free Cash Flow | 29.20 |
| Price | 130.24 |
| Earnings Yield | 3.18% |
| Market Cap | 201.91B |
| PEGY Ratio | 4.604 |
| Operating PE Ratio | 20.72 |
| Normalized PE Ratio | 28.83 |